Remix Therapeutics
PrivateLast Round
M&A
Jun 24, 2026
Est. Valuation
$226M
Total Funding Raised
$167M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing to treat diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remix Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Remix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jun 24, 2026 | ||||
| VC Round | Jan 3, 2024 | ||||
| Series B | May 17, 2022 | ||||
| Series A | Dec 8, 2020 |
Remix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A, M&A, Series B, VC Round, Seed |
| Surveyor Capital | VC Round, Series B |
| ARCH Venture Partners | Series A, VC Round, Series B |
| The Chernin Group | Series A, Series B, VC Round |
| ARCH Venture Partners | Series A, VC Round, Series B |
| Forge Life Science Partners | M&A |
| Foresite Capital | VC Round, M&A, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 37% MoM, reaching 4.5K.
- Apr 21, 2026
Results from Phase 1/2 ARIA Trial of REM-422 to be presented at 2026 ASCO Annual Meeting.
Remix Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remix Therapeutics's valuation, stock price, and market status.